Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy
Author(s) -
Isabelle Jéru,
MarieChristine Vantyghem,
Élise Bismuth,
Pascale Cervera,
Sara Barraud,
Martine Auclair,
Camille Vatier,
Olivier Lascols,
David B. Savage,
Corinne Vigouroux
Publication year - 2019
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2019-00849
Subject(s) - lipodystrophy , medicine , genetics , biology , human immunodeficiency virus (hiv) , immunology , viral load , antiretroviral therapy
Heterozygous frameshift variants in PLIN1 encoding perilipin-1, a key protein for lipid droplet formation and triglyceride metabolism, have been implicated in familial partial lipodystrophy type 4 (FPLD4), a rare entity with only six families reported worldwide. The pathogenicity of other PLIN1 null variants identified in patients with diabetes and/or hyperinsulinemia was recently questioned because of the absence of lipodystrophy in these individuals and the elevated frequency of PLIN1 null variants in the general population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom